GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » Debt-to-Revenue

Aroa Biosurgery (ASX:ARX) Debt-to-Revenue : 0.10 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aroa Biosurgery Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Aroa Biosurgery's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was A$0.92 Mil. Aroa Biosurgery's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was A$5.90 Mil. Aroa Biosurgery's annualized Revenue for the quarter that ended in Mar. 2024 was A$68.76 Mil. Aroa Biosurgery's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.10.

Aroa Biosurgery Debt-to-Revenue Historical Data

The historical data trend for Aroa Biosurgery's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aroa Biosurgery Debt-to-Revenue Chart

Aroa Biosurgery Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Revenue
N/A 0.73 0.15 0.11 0.11

Aroa Biosurgery Semi-Annual Data
Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial 0.14 0.10 0.10 0.11 0.10

Competitive Comparison of Aroa Biosurgery's Debt-to-Revenue

For the Medical Devices subindustry, Aroa Biosurgery's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aroa Biosurgery's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aroa Biosurgery's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Aroa Biosurgery's Debt-to-Revenue falls into.


Aroa Biosurgery Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Aroa Biosurgery's Debt-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.921 + 5.899) / 63.357
=0.11

Aroa Biosurgery's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.921 + 5.899) / 68.764
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Mar. 2024) Revenue data.

Aroa Biosurgery Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Aroa Biosurgery's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Aroa Biosurgery (ASX:ARX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » Debt-to-Revenue
Comparable Companies
ASX:IPD ASX:AVR ASX:CYC ASX:4DX ASX:EMV ASX:IMR ASX:MX1 ASX:SOM ASX:UBI ASX:NTI ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022
Website
https://www.aroabio.com
Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.

Aroa Biosurgery (ASX:ARX) Headlines

No Headlines